{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60001063",
    "licUnit": "1",
    "validDate": "2027-12-07 00:00:00.000",
    "issueDate": "2017-12-07 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000106308",
    "prodNameC": "達癬治® 注射劑",
    "prodNameE": "TALTZ® injection",
    "indicationsName": [
        "1.\t斑塊性乾癬：適用於治療適合接受全身性治療的中至重度斑塊性乾癬之6 歲以上兒童及成人病人。\r\n2.\t乾癬性關節炎：適用於治療患有活動性乾癬性關節炎之成人病人。\r\n3.\t僵直性脊椎炎：適用於治療活動性僵直性脊椎炎之成人病人。\r\n4.     無放射影像確認之中軸性脊椎關節炎(Non-radiographic axial \r\n       spondyloarthritis，簡稱nr-axSpA) : 用於治療嚴重活動性無放射影像確認\r\n       之中軸性脊椎關節炎且符合下列所有條件的成人病人：\r\n       (1) 對非類固醇抗發炎藥物(NSAID)治療反應不佳或無法耐受。\r\n       (2) 其C反應蛋白(C-reactive protein，簡稱CRP)濃度升高。\r\n       (3) 核磁共振造影(MRI)檢查證據顯示有發炎的客觀跡象。\r\n       (4) HLA-B27陽性。\r\n"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "各100支以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "1毫升",
            "packageUnit": "2V"
        },
        {
            "packageSpec": "1毫升含藥",
            "packageUnit": "D6"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "3DFD178C-1853-47B3-8F80-1DED8A60C102",
    "subCategory": [],
    "ingredientsDesc": [
        "Ixekizumab"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "5E",
        "5F"
    ],
    "applicantName": "台灣禮來股份有限公司",
    "applicantAddr": "臺北市信義區松高路9號14樓、11號14樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2022-12-07",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "AADDCFFB-E06C-4B02-A961-7789D6458782",
            "factoryCode": "1",
            "factoryName": "ELI LILLY AND COMPANY",
            "factoryAddr": "INDIANAPOLIS, INDIANA 46285, U.S.A.",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FUS0073100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "E13531A3-7EDF-415B-8B41-B7EBC7B73183",
            "factoryCode": "2",
            "factoryName": "ELI LILLY KINSALE LIMITED",
            "factoryAddr": "DUNDERROW, KINSALE, P17 NY71, IRELAND",
            "factoryCompanyAddr": null,
            "countryCode": "IE",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FIE0110100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "9200081320",
            "ingredientsName": "Ixekizumab",
            "ingredientsDesc": "Ixekizumab",
            "concentDesc": "",
            "concent": "80.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L04AC13"
        }
    ],
    "licBaseId": "623A41DF-3AC2-4EAC-8696-921B2146350D"
}